Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Díez

Showing results (1-10 of 490) with videos related to

Pageof 49
Sort By:
Hypertension (Dallas, Tex. : 1979)|May 1, 2004
Profibrotic effects of angiotensin II in the heart: a matter of mediatorsJavier Díez
European Journal of Heart Failure|October 22, 2016
Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapyJavier Díez
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 5, 2014
Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actionsJavier Díez
The Medical Clinics of North America|May 12, 2009
Towards a new paradigm about hypertensive heart diseaseJavier Díez
Nature Clinical Practice. Cardiovascular Medicine|December 3, 2008
Do microRNAs regulate myocardial fibrosis?Javier Díez
Journal of Hypertension|April 21, 2004
Angiotensin II and the hypertensive heart: a role for the AT2 receptor?Javier Díez
Medicina Clinica|September 24, 2011
[Biochemical diagnosis of left ventricular remodelling in refractory hypertension]Javier Díez
Circulation Journal : Official Journal of the Japanese Circulation Society|September 6, 2008
Diagnosis and treatment of myocardial fibrosis in hypertensive heart diseaseJavier Díez
Cardiovascular Research|June 25, 2010
Altered degradation of extracellular matrix in myocardial remodelling: the growing role of cathepsins and cystatinsJavier Díez
Clinical Therapeutics|July 25, 2006
Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertensionJavier Díez
Pageof 49

Showing results (1-10 of 490) with videos related to

Sort By:
Pageof 49
Hypertension (Dallas, Tex. : 1979)|May 1, 2004
Profibrotic effects of angiotensin II in the heart: a matter of mediatorsJavier Díez
European Journal of Heart Failure|October 22, 2016
Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapyJavier Díez
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 5, 2014
Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actionsJavier Díez
The Medical Clinics of North America|May 12, 2009
Towards a new paradigm about hypertensive heart diseaseJavier Díez
Nature Clinical Practice. Cardiovascular Medicine|December 3, 2008
Do microRNAs regulate myocardial fibrosis?Javier Díez
Journal of Hypertension|April 21, 2004
Angiotensin II and the hypertensive heart: a role for the AT2 receptor?Javier Díez
Medicina Clinica|September 24, 2011
[Biochemical diagnosis of left ventricular remodelling in refractory hypertension]Javier Díez
Circulation Journal : Official Journal of the Japanese Circulation Society|September 6, 2008
Diagnosis and treatment of myocardial fibrosis in hypertensive heart diseaseJavier Díez
Cardiovascular Research|June 25, 2010
Altered degradation of extracellular matrix in myocardial remodelling: the growing role of cathepsins and cystatinsJavier Díez
Clinical Therapeutics|July 25, 2006
Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertensionJavier Díez
Pageof 49